Director · Humacyte, Inc. · Humacyte, Inc. — Stock Options (right to buy)
Side
A
Value
—
Shares
125.0K
Price
—
Executed
Oct 6, 2026
Disclosed
Oct 7, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Oct 6 executedOct 7, 2026 disclosed
HUMA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Kuznik Paul Brian filed this Form 4 reporting a grant or award of HUMA on Oct 6, 2026. It became public on Oct 7, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Kuznik Paul Briancik:0002156537
Issuer
Humacyte, Inc.cik:0001818382
Revision history · 0
No field has changed since this record was first ingested.
